Triglycerides, Atherosclerosis, and Cardiovascular Outcome Studies: Focus on Omega-3 Fatty Acids
Authors:
- Yehuda HandelsmanYHYehuda Handelsman
- Michael D. ShapiroMSMichael D. Shapiro
- 1 January 2017
- journal article
- review article
- Published by Elsevier in Endocrine Practice
- Vol. 23 (1) , 100-112
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatmentEuropean Heart Journal, 2013
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with DysglycemiaNew England Journal of Medicine, 2012
- The Role of Triglycerides in AtherosclerosisCurrent Cardiology Reports, 2011
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseNature Genetics, 2011
- n–3 Fatty Acids and Cardiovascular Events after Myocardial InfarctionNew England Journal of Medicine, 2010
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007